Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
For many users, GLP-1 drugs are not a long-term commitment but rather a step along the way in their weight loss or wellness journey
What can patients expect after receiving a Cingal injection
But when it reaches the market, here's what to expect based on the current GLP-1 insurance landscape: If Approved for Type 2 Diabetes Most commercial insurance plans will cover it, especially if it demonstrates A1C reduction comparable to or exceeding tirzepatide Prior authorization will likely be required Step therapy (try metformin first, then other agents) is standard Copays with manufacturer savings: potentially $25$50/month If Approved for Obesity/Weight Management Coverage remains highly variable, and many plans still exclude weight management medications Medicare Part D: Congress has been debating coverage of anti-obesity medications, but it remains excluded as of early 2026 Self-insured employers increasingly adding GLP-1 coverage, but it's employer-specific Expect significant prior authorization requirements (BMI thresholds, failed diet attempts) The practical reality: even when retatrutide is approved, many people will face the same insurance barriers that currently exist for Wegovy and Zepbound
The anti-aging benefits of adequate nutrition become particularly relevant during aggressive weight loss protocols, as nutrient deficiencies can accelerate age-related decline
In the SURMOUNT-1 trial, tirzepatide 15 mg weekly produced mean weight loss of 22.5% at 72 weeks significantly exceeding semaglutide results
